0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Musculoskeletal Disorders Therapeutics Market Insights, Forecast to 2028
Published Date: February 2022
|
Report Code: QYRE-Auto-23X5927
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Musculoskeletal Disorders Therapeutics Market Insights Forecast to 2028

Global Musculoskeletal Disorders Therapeutics Market Insights, Forecast to 2028

Code: QYRE-Auto-23X5927
Report
February 2022
Pages:114
QYResearch
Description
Table of Content
Tables & Figures
Market Analysis and Insights: Global Musculoskeletal Disorders Therapeutics Market

The global Musculoskeletal Disorders Therapeutics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Biologics accounting for % of the Musculoskeletal Disorders Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Osteoarthritis segment is altered to an % CAGR throughout this forecast period.
China Musculoskeletal Disorders Therapeutics market size is valued at US$ million in 2021, while the North America and Europe Musculoskeletal Disorders Therapeutics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Musculoskeletal Disorders Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Musculoskeletal Disorders Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Musculoskeletal Disorders Therapeutics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Musculoskeletal Disorders Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Musculoskeletal Disorders Therapeutics market.
Global Musculoskeletal Disorders Therapeutics Scope and Market Size
Musculoskeletal Disorders Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Musculoskeletal Disorders Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Biologics
Small Molecules

Segment by Application

Osteoarthritis
Osteoporosis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia

BY COMPANY

AbbVie
Johnson & Johnson
Amgen
Pfizer
F. Hoffmann-La Roche
Eli Lilly
Merck
Novartis
AstraZeneca
Astellas
AB Sciences
3SBio
Samsung Bioepis
Sanofi
Taisho Pharmaceutical
Takeda
Zosano Pharma
LG Life Sciences

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Biologics
1.2.3 Small Molecules
1.3 Market by Application
1.3.1 Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Osteoarthritis
1.3.3 Osteoporosis
1.3.4 Psoriatic Arthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Fibromyalgia
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Musculoskeletal Disorders Therapeutics Market Perspective (2017-2028)
2.2 Musculoskeletal Disorders Therapeutics Growth Trends by Region
2.2.1 Musculoskeletal Disorders Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Musculoskeletal Disorders Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Musculoskeletal Disorders Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Musculoskeletal Disorders Therapeutics Market Dynamics
2.3.1 Musculoskeletal Disorders Therapeutics Industry Trends
2.3.2 Musculoskeletal Disorders Therapeutics Market Drivers
2.3.3 Musculoskeletal Disorders Therapeutics Market Challenges
2.3.4 Musculoskeletal Disorders Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Musculoskeletal Disorders Therapeutics Players by Revenue
3.1.1 Global Top Musculoskeletal Disorders Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Musculoskeletal Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Musculoskeletal Disorders Therapeutics Revenue
3.4 Global Musculoskeletal Disorders Therapeutics Market Concentration Ratio
3.4.1 Global Musculoskeletal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Musculoskeletal Disorders Therapeutics Revenue in 2021
3.5 Musculoskeletal Disorders Therapeutics Key Players Head office and Area Served
3.6 Key Players Musculoskeletal Disorders Therapeutics Product Solution and Service
3.7 Date of Enter into Musculoskeletal Disorders Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Musculoskeletal Disorders Therapeutics Breakdown Data by Type
4.1 Global Musculoskeletal Disorders Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Type (2023-2028)
5 Musculoskeletal Disorders Therapeutics Breakdown Data by Application
5.1 Global Musculoskeletal Disorders Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Musculoskeletal Disorders Therapeutics Market Size (2017-2028)
6.2 North America Musculoskeletal Disorders Therapeutics Market Size by Type
6.2.1 North America Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Musculoskeletal Disorders Therapeutics Market Share by Type (2017-2028)
6.3 North America Musculoskeletal Disorders Therapeutics Market Size by Application
6.3.1 North America Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Musculoskeletal Disorders Therapeutics Market Share by Application (2017-2028)
6.4 North America Musculoskeletal Disorders Therapeutics Market Size by Country
6.4.1 North America Musculoskeletal Disorders Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Musculoskeletal Disorders Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Musculoskeletal Disorders Therapeutics Market Size (2017-2028)
7.2 Europe Musculoskeletal Disorders Therapeutics Market Size by Type
7.2.1 Europe Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Musculoskeletal Disorders Therapeutics Market Share by Type (2017-2028)
7.3 Europe Musculoskeletal Disorders Therapeutics Market Size by Application
7.3.1 Europe Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Musculoskeletal Disorders Therapeutics Market Share by Application (2017-2028)
7.4 Europe Musculoskeletal Disorders Therapeutics Market Size by Country
7.4.1 Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Type
8.2.1 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Application
8.3.1 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region
8.4.1 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Musculoskeletal Disorders Therapeutics Market Size (2017-2028)
9.2 Latin America Musculoskeletal Disorders Therapeutics Market Size by Type
9.2.1 Latin America Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Musculoskeletal Disorders Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Musculoskeletal Disorders Therapeutics Market Size by Application
9.3.1 Latin America Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Musculoskeletal Disorders Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Musculoskeletal Disorders Therapeutics Market Size by Country
9.4.1 Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Type
10.2.1 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Application
10.3.1 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country
10.4.1 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Musculoskeletal Disorders Therapeutics Introduction
11.1.4 AbbVie Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)
11.1.5 AbbVie Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Musculoskeletal Disorders Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)
11.2.5 Johnson & Johnson Recent Developments
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Musculoskeletal Disorders Therapeutics Introduction
11.3.4 Amgen Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)
11.3.5 Amgen Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Musculoskeletal Disorders Therapeutics Introduction
11.4.4 Pfizer Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)
11.4.5 Pfizer Recent Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)
11.5.5 F. Hoffmann-La Roche Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Musculoskeletal Disorders Therapeutics Introduction
11.6.4 Eli Lilly Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)
11.6.5 Eli Lilly Recent Developments
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Musculoskeletal Disorders Therapeutics Introduction
11.7.4 Merck Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)
11.7.5 Merck Recent Developments
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Musculoskeletal Disorders Therapeutics Introduction
11.8.4 Novartis Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)
11.8.5 Novartis Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Musculoskeletal Disorders Therapeutics Introduction
11.9.4 AstraZeneca Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)
11.9.5 AstraZeneca Recent Developments
11.10 Astellas
11.10.1 Astellas Company Details
11.10.2 Astellas Business Overview
11.10.3 Astellas Musculoskeletal Disorders Therapeutics Introduction
11.10.4 Astellas Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)
11.10.5 Astellas Recent Developments
11.11 AB Sciences
11.11.1 AB Sciences Company Details
11.11.2 AB Sciences Business Overview
11.11.3 AB Sciences Musculoskeletal Disorders Therapeutics Introduction
11.11.4 AB Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)
11.11.5 AB Sciences Recent Developments
11.12 3SBio
11.12.1 3SBio Company Details
11.12.2 3SBio Business Overview
11.12.3 3SBio Musculoskeletal Disorders Therapeutics Introduction
11.12.4 3SBio Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)
11.12.5 3SBio Recent Developments
11.13 Samsung Bioepis
11.13.1 Samsung Bioepis Company Details
11.13.2 Samsung Bioepis Business Overview
11.13.3 Samsung Bioepis Musculoskeletal Disorders Therapeutics Introduction
11.13.4 Samsung Bioepis Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)
11.13.5 Samsung Bioepis Recent Developments
11.14 Sanofi
11.14.1 Sanofi Company Details
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Musculoskeletal Disorders Therapeutics Introduction
11.14.4 Sanofi Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)
11.14.5 Sanofi Recent Developments
11.15 Taisho Pharmaceutical
11.15.1 Taisho Pharmaceutical Company Details
11.15.2 Taisho Pharmaceutical Business Overview
11.15.3 Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Introduction
11.15.4 Taisho Pharmaceutical Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)
11.15.5 Taisho Pharmaceutical Recent Developments
11.16 Takeda
11.16.1 Takeda Company Details
11.16.2 Takeda Business Overview
11.16.3 Takeda Musculoskeletal Disorders Therapeutics Introduction
11.16.4 Takeda Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)
11.16.5 Takeda Recent Developments
11.17 Zosano Pharma
11.17.1 Zosano Pharma Company Details
11.17.2 Zosano Pharma Business Overview
11.17.3 Zosano Pharma Musculoskeletal Disorders Therapeutics Introduction
11.17.4 Zosano Pharma Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)
11.17.5 Zosano Pharma Recent Developments
11.18 LG Life Sciences
11.18.1 LG Life Sciences Company Details
11.18.2 LG Life Sciences Business Overview
11.18.3 LG Life Sciences Musculoskeletal Disorders Therapeutics Introduction
11.18.4 LG Life Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)
11.18.5 LG Life Sciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Biologics
    Table 3. Key Players of Small Molecules
    Table 4. Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Musculoskeletal Disorders Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Musculoskeletal Disorders Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Musculoskeletal Disorders Therapeutics Market Share by Region (2017-2022)
    Table 8. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Musculoskeletal Disorders Therapeutics Market Share by Region (2023-2028)
    Table 10. Musculoskeletal Disorders Therapeutics Market Trends
    Table 11. Musculoskeletal Disorders Therapeutics Market Drivers
    Table 12. Musculoskeletal Disorders Therapeutics Market Challenges
    Table 13. Musculoskeletal Disorders Therapeutics Market Restraints
    Table 14. Global Musculoskeletal Disorders Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Musculoskeletal Disorders Therapeutics Revenue Share by Players (2017-2022)
    Table 16. Global Top Musculoskeletal Disorders Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Disorders Therapeutics as of 2021)
    Table 17. Ranking of Global Top Musculoskeletal Disorders Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Musculoskeletal Disorders Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Musculoskeletal Disorders Therapeutics Product Solution and Service
    Table 21. Date of Enter into Musculoskeletal Disorders Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type (2017-2022)
    Table 25. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type (2023-2028)
    Table 27. Global Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Musculoskeletal Disorders Therapeutics Revenue Share by Application (2017-2022)
    Table 29. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Musculoskeletal Disorders Therapeutics Revenue Share by Application (2023-2028)
    Table 31. North America Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Musculoskeletal Disorders Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Musculoskeletal Disorders Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 61. AbbVie Company Details
    Table 62. AbbVie Business Overview
    Table 63. AbbVie Musculoskeletal Disorders Therapeutics Product
    Table 64. AbbVie Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 65. AbbVie Recent Developments
    Table 66. Johnson & Johnson Company Details
    Table 67. Johnson & Johnson Business Overview
    Table 68. Johnson & Johnson Musculoskeletal Disorders Therapeutics Product
    Table 69. Johnson & Johnson Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 70. Johnson & Johnson Recent Developments
    Table 71. Amgen Company Details
    Table 72. Amgen Business Overview
    Table 73. Amgen Musculoskeletal Disorders Therapeutics Product
    Table 74. Amgen Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 75. Amgen Recent Developments
    Table 76. Pfizer Company Details
    Table 77. Pfizer Business Overview
    Table 78. Pfizer Musculoskeletal Disorders Therapeutics Product
    Table 79. Pfizer Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 80. Pfizer Recent Developments
    Table 81. F. Hoffmann-La Roche Company Details
    Table 82. F. Hoffmann-La Roche Business Overview
    Table 83. F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Product
    Table 84. F. Hoffmann-La Roche Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 85. F. Hoffmann-La Roche Recent Developments
    Table 86. Eli Lilly Company Details
    Table 87. Eli Lilly Business Overview
    Table 88. Eli Lilly Musculoskeletal Disorders Therapeutics Product
    Table 89. Eli Lilly Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 90. Eli Lilly Recent Developments
    Table 91. Merck Company Details
    Table 92. Merck Business Overview
    Table 93. Merck Musculoskeletal Disorders Therapeutics Product
    Table 94. Merck Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 95. Merck Recent Developments
    Table 96. Novartis Company Details
    Table 97. Novartis Business Overview
    Table 98. Novartis Musculoskeletal Disorders Therapeutics Product
    Table 99. Novartis Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 100. Novartis Recent Developments
    Table 101. AstraZeneca Company Details
    Table 102. AstraZeneca Business Overview
    Table 103. AstraZeneca Musculoskeletal Disorders Therapeutics Product
    Table 104. AstraZeneca Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 105. AstraZeneca Recent Developments
    Table 106. Astellas Company Details
    Table 107. Astellas Business Overview
    Table 108. Astellas Musculoskeletal Disorders Therapeutics Product
    Table 109. Astellas Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 110. Astellas Recent Developments
    Table 111. AB Sciences Company Details
    Table 112. AB Sciences Business Overview
    Table 113. AB Sciences Musculoskeletal Disorders Therapeutics Product
    Table 114. AB Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 115. AB Sciences Recent Developments
    Table 116. 3SBio Company Details
    Table 117. 3SBio Business Overview
    Table 118. 3SBio Musculoskeletal Disorders Therapeutics Product
    Table 119. 3SBio Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 120. 3SBio Recent Developments
    Table 121. Samsung Bioepis Company Details
    Table 122. Samsung Bioepis Business Overview
    Table 123. Samsung Bioepis Musculoskeletal Disorders Therapeutics Product
    Table 124. Samsung Bioepis Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 125. Samsung Bioepis Recent Developments
    Table 126. Sanofi Company Details
    Table 127. Sanofi Business Overview
    Table 128. Sanofi Musculoskeletal Disorders Therapeutics Product
    Table 129. Sanofi Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 130. Sanofi Recent Developments
    Table 131. Taisho Pharmaceutical Company Details
    Table 132. Taisho Pharmaceutical Business Overview
    Table 133. Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Product
    Table 134. Taisho Pharmaceutical Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 135. Taisho Pharmaceutical Recent Developments
    Table 136. Takeda Company Details
    Table 137. Takeda Business Overview
    Table 138. Takeda Musculoskeletal Disorders Therapeutics Product
    Table 139. Takeda Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 140. Takeda Recent Developments
    Table 141. Zosano Pharma Company Details
    Table 142. Zosano Pharma Business Overview
    Table 143. Zosano Pharma Musculoskeletal Disorders Therapeutics Product
    Table 144. Zosano Pharma Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 145. Zosano Pharma Recent Developments
    Table 146. LG Life Sciences Company Details
    Table 147. LG Life Sciences Business Overview
    Table 148. LG Life Sciences Musculoskeletal Disorders Therapeutics Product
    Table 149. LG Life Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 150. LG Life Sciences Recent Developments
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Musculoskeletal Disorders Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Biologics Features
    Figure 3. Small Molecules Features
    Figure 4. Global Musculoskeletal Disorders Therapeutics Market Share by Application: 2021 VS 2028
    Figure 5. Osteoarthritis Case Studies
    Figure 6. Osteoporosis Case Studies
    Figure 7. Psoriatic Arthritis Case Studies
    Figure 8. Ankylosing Spondylitis Case Studies
    Figure 9. Fibromyalgia Case Studies
    Figure 10. Musculoskeletal Disorders Therapeutics Report Years Considered
    Figure 11. Global Musculoskeletal Disorders Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Musculoskeletal Disorders Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Musculoskeletal Disorders Therapeutics Market Share by Region: 2021 VS 2028
    Figure 14. Global Musculoskeletal Disorders Therapeutics Market Share by Players in 2021
    Figure 15. Global Top Musculoskeletal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Disorders Therapeutics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Musculoskeletal Disorders Therapeutics Revenue in 2021
    Figure 17. North America Musculoskeletal Disorders Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Musculoskeletal Disorders Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 19. North America Musculoskeletal Disorders Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 20. North America Musculoskeletal Disorders Therapeutics Market Size Share by Country (2017-2028)
    Figure 21. United States Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Musculoskeletal Disorders Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Musculoskeletal Disorders Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Musculoskeletal Disorders Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Musculoskeletal Disorders Therapeutics Market Size Share by Country (2017-2028)
    Figure 27. Germany Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Musculoskeletal Disorders Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Musculoskeletal Disorders Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Musculoskeletal Disorders Therapeutics Market Size Share by Region (2017-2028)
    Figure 37. China Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Musculoskeletal Disorders Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Musculoskeletal Disorders Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Musculoskeletal Disorders Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Musculoskeletal Disorders Therapeutics Market Size Share by Country (2017-2028)
    Figure 47. Mexico Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size Share by Country (2017-2028)
    Figure 53. Turkey Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. AbbVie Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)
    Figure 57. Johnson & Johnson Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)
    Figure 58. Amgen Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)
    Figure 59. Pfizer Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)
    Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)
    Figure 61. Eli Lilly Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)
    Figure 62. Merck Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)
    Figure 63. Novartis Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)
    Figure 64. AstraZeneca Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)
    Figure 65. Astellas Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)
    Figure 66. AB Sciences Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)
    Figure 67. 3SBio Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)
    Figure 68. Samsung Bioepis Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)
    Figure 69. Sanofi Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)
    Figure 70. Taisho Pharmaceutical Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)
    Figure 71. Takeda Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)
    Figure 72. Zosano Pharma Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)
    Figure 73. LG Life Sciences Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String

RELATED REPORTS

Global Recombinant Human Fibroblast Growth Factor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34A18264
Mon Nov 18 00:00:00 UTC 2024

Add to Cart

Global Custom Polyclonal Antibody Production Service Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-17I18806
Mon Nov 18 00:00:00 UTC 2024

Add to Cart

Cytogenetics Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-31E8575
Mon Nov 18 00:00:00 UTC 2024

Add to Cart

Automated Coagulation Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-21B8891
Mon Nov 18 00:00:00 UTC 2024

Add to Cart